x

Cerca un progetto di ricerca

* (*) campo obbligatorio

45 Risultato/i

Ordinato per

Finanziato da un ente associato a IRDiRC =

Progetti di ricerca

GERMANIA

Berlin
BERLIN

Finanziato da un ente associato a IRDiRCMAGEA1-TCR : MAGE-A1 TCR gene therapy of Multiple Myeloma as an example
Charité - Universitätsmedizin Berlin (CVK)
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

SPAGNA

Castilla - León
SALAMANCA

Finanziato da un ente associato a IRDiRCRegulation of the microenvironment in multiple myeloma via microRNAs: role in the disease and therapeutic possibilities
Centro de Investigación del Cáncer (USAL-CSIC)
Centro de Investigación del Cáncer

SPAGNA

Castilla - León
SALAMANCA

SPAGNA

Castilla - León
SALAMANCA

Finanziato da un ente associato a IRDiRCUltra-sensitive evaluation of residual disease as a biomarker of curability in two models of multiple myeloma
IBSAL - Instituto de Investigación Biomédica de Salamanca
Mieloma múltiple y nuevos fármacos

SPAGNA

Castilla - León
SALAMANCA

SPAGNA

Castilla - León
SALAMANCA

Finanziato da un ente associato a IRDiRCStudy of the functional status of p53 in multiple myeloma and its impact on the therapeutic response and survival of patients
IBSAL - Instituto de Investigación Biomédica de Salamanca
Mieloma múltiple y nuevos fármacos

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCMechanisms of immunological control involved in the progression after treatment in multiple myeloma
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Grupo de investigación en hematología oncológica

SPAGNA

Madrid
MADRID

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCUltra-sensitive evaluation of residual disease as a biomarker of curability in two models of multiple myeloma
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en hematología traslacional

SPAGNA

Navarra
PAMPLONA

Finanziato da un ente associato a IRDiRCDetection and functional validation of the long non-coding RNAs specific in plasma cell in Multiple Myeloma
CIMA - Centro de Investigación Médica Aplicada
Grupo de Mecanismos Epigenéticos del Cáncer

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRag and aid biology
Institution: Information not provided - US

FRANCIA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANIA

Baden-Württemberg
HEIDELBERG

Finanziato da un ente associato a IRDiRCERA-NET TRANSCAN: TORPEDO - Targeting Of Resistance in PEDiatric Oncology (coordination)
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ITALIA

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Finanziato da un ente associato a IRDiRCUK Infrastructure for Large-scale Clinical Genomics Research
Barts and The London School of Medicine and Dentistry
William Harvey Research Institute

REGNO UNITO; GRAN BRETAGNA

Tyne & Wear
NEWCASTLE UPON TYNE

Finanziato da un ente associato a IRDiRCNewcastle University Single Cell Functional Genomics Unit (NUSCU)
Newcastle University
Institute of Genetic Medicine

REGNO UNITO; GRAN BRETAGNA

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Progetti di ricerca multicentrici